Origin and proliferation of multiple-drug resistance in bacterial pathogens
about
How Can Vaccines Contribute to Solving the Antimicrobial Resistance Problem?Glycosyltransferases and Transpeptidases/Penicillin-Binding Proteins: Valuable Targets for New AntibacterialsReview of Antimicrobial Resistance in the Environment and Its Relevance to Environmental RegulatorsAnti-infective Activity of 2-Cyano-3-Acrylamide Inhibitors with Improved Drug-Like Properties against Two Intracellular Pathogens.Cell scale host-pathogen modeling: another branch in the evolution of constraint-based methods.Spontaneous mutations in the flhD operon generate motility heterogeneity in Escherichia coli biofilm.Fitness Costs of Drug Resistance Mutations in Multidrug-Resistant Mycobacterium tuberculosis: A Household-Based Case-Control StudyANTIMICROBIAL RESISTANCE OF ESCHERICHIA COLI STRAINS ISOLATED FROM URINE AT OUTPATIENT POPULATION: A SINGLE LABORATORY EXPERIENCENovel antimicrobial peptide-modified azithromycin-loaded liposomes against methicillin-resistant Staphylococcus aureus.Where Sepsis and Antimicrobial Resistance Countermeasures Converge.Host population structure and treatment frequency maintain balancing selection on drug resistance.Contemporary challenges and opportunities in the diagnosis and outbreak detection of multidrug-resistant infectious disease.Considerations and caveats in anti-virulence drug development.Raf-kinase inhibitor GW5074 shows antibacterial activity against methicillin-resistant Staphylococcus aureus and potentiates the activity of gentamicin.A Perspective on the Trends and Challenges Facing Porphyrin-Based Anti-Microbial Materials.Recent advances in biochemical and molecular diagnostics for the rapid detection of antibiotic-resistant Enterobacteriaceae: a focus on ß-lactam resistance.An overview of nanofiber-based antibacterial drug design.Epistasis and the Evolution of Antimicrobial Resistance.Factors pivotal for designing of nanoantimicrobials: an exposition.Development of botanicals to combat antibiotic resistance.Broad-range lytic bacteriophages that kill Staphylococcus aureus local field strains.Perspectives on polymeric nanostructures for the therapeutic application of antimicrobial peptides.Sugar-Grafted Cyclodextrin Nanocarrier as a "Trojan Horse" for Potentiating Antibiotic Activity.Photoexcited quantum dots for killing multidrug-resistant bacteria.The Search for Herbal Antibiotics: An In-Silico Investigation of Antibacterial Phytochemicals.Shigella flexneri serotype 3a: the rise of a superbug.Vibrio Pathogens: A Public Health Concern in Rural Water Resources in Sub-Saharan Africa.Salmonella Typhimurium exhibits fluoroquinolone resistance mediated by the accumulation of the antioxidant molecule H2S in a CysK-dependent manner.A Coculture-Based Approach for Screening Campaigns Aimed at Identifying Novel Pseudomonas aeruginosa Quorum Sensing Inhibitors.Propyl-5-hydroxy-3-methyl-1-phenyl-1H-pyrazole-4-carbodithioate (HMPC): a new bacteriostatic agent against methicillin-resistant Staphylococcus aureus.Insights into the processes that drive the evolution of drug resistance in Mycobacterium tuberculosis
P2860
Q26748155-11D1313A-DC9D-4392-834D-9291447D1D03Q26749531-425A0874-654F-48E1-8A30-518591896841Q28067678-FFC79BFF-CBBD-463A-BA1A-DDD0978C2192Q36006797-01E66C19-595F-4452-9CF7-912DD2537459Q36124640-7E319782-1464-4B0B-A6E4-24060CDB892DQ36184490-C8D25C09-95D9-4139-9D37-DE0FE96C37FFQ36365273-4E66C8D5-7E02-4000-A262-981B389BC500Q36853066-7F61B548-044A-4666-8262-62CA96E860B9Q37515614-74DB4B0E-149E-457C-ABB8-DE769033D3A8Q37625798-9FC2B7B7-D402-4B11-A37A-B274F9BC642EQ38611162-877A3AF7-A634-4147-A021-4D5AABCC067CQ38803671-AE60CF69-1BE4-4EFC-B842-05F7E37757BCQ38810589-5AD9CC6E-EAC7-4686-AFB9-39BEB02C84E1Q38819114-BF2497F3-96DD-4A74-963E-B14FBC4AB117Q38858993-6B20F93E-3D8A-4E61-9F10-32EC3FF7E53EQ39109739-47944973-B58E-4A74-A841-86E5460835C0Q39122330-98D2B4FE-103A-4BB1-B530-A0F6EB7E84AFQ39162611-A8D60E48-9A33-4636-87C8-8D9F68E88A69Q39250173-45108469-33A5-4522-A63F-2FE40206509DQ40059294-55CBDDEF-1C3C-48DB-8756-A2D73E6B2313Q40120490-F8271F4B-F06A-4726-AC6E-27247322C7B7Q40635352-3BEF6165-15E9-4C63-97B9-86ED6C4EE8FEQ40824085-261C3F37-629A-4944-8F3A-8C08C7AF68DBQ40828612-322E9504-E3EB-4C8C-9175-A4696D40E527Q41202246-A8E8A154-C821-468A-8BE6-279F1CD78999Q41263203-97E9BA76-8DB5-403F-881A-6F3EBB5E9715Q41921695-8EEC7DEE-3850-4EC9-BBC8-DACA67B495D2Q46501077-EE3E0564-2AA2-4460-A428-FFB58A3A9049Q47411023-E5C3E7DC-05C5-4D20-8E46-9B858BB59E64Q53687606-70A93F85-2CAB-48DE-B7B4-061089EA089DQ56828266-A60867F6-D4BA-427B-AA39-150564404266
P2860
Origin and proliferation of multiple-drug resistance in bacterial pathogens
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Origin and proliferation of multiple-drug resistance in bacterial pathogens
@ast
Origin and proliferation of multiple-drug resistance in bacterial pathogens
@en
Origin and proliferation of multiple-drug resistance in bacterial pathogens
@nl
type
label
Origin and proliferation of multiple-drug resistance in bacterial pathogens
@ast
Origin and proliferation of multiple-drug resistance in bacterial pathogens
@en
Origin and proliferation of multiple-drug resistance in bacterial pathogens
@nl
prefLabel
Origin and proliferation of multiple-drug resistance in bacterial pathogens
@ast
Origin and proliferation of multiple-drug resistance in bacterial pathogens
@en
Origin and proliferation of multiple-drug resistance in bacterial pathogens
@nl
P2093
P2860
P3181
P356
P1476
Origin and proliferation of multiple-drug resistance in bacterial pathogens
@en
P2093
Hsiao-Han Chang
Thomas F. O'Brien
Yonatan H. Grad
P2860
P304
P3181
P356
10.1128/MMBR.00039-14
P407
P577
2015-03-01T00:00:00Z